InvestorsHub Logo

Lemoncat

05/27/21 9:05 AM

#360517 RE: stevo99 #360510

They were a $1.5B company

before COVID.
before partnering with GSK.
before running a successful COVID trial.
before getting EUA for their drug.

Sure they're far ahead of us with partnerships and grants


In that they have a partnership with GSK, a successful COVID drug, EUA from the FDA and lots of funding. They're not just far ahead of us, they're in an entirely different league.

When we get:
A big pharma partner.
Run a successful COVID trial.
Receive EUA from the FDA

Then we will probably be a multi-billion dollar company. My hope is that COVID results spark a buyout in the $2B range this fall.

Go IPIX!